Industry Focus

The Cupertino company plans to open healthcare clinics that will rely heavily on its technology. Also, Gilead Sciences partners with Sangamo Therapeutics on gene-editing.

Thanks to LegalZoom for supporting Motley Fool.  Get special savings by going to use code Fool at checkout.

Direct download: 20180228_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT